Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa ...

Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.

On 1 December, the fortunes of the UK pharma sector changed radically, with the UK Government becoming the first in the world ...

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

If Richard Padzur retires, he would become one of several high-ranking FDA officials who left the agency in 2025.

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.

Citizen Health has entered a multi-year strategic partnership with UCB for expediting drug development across five rare ...

With an eye on 2026, the healthcare editorial team reflects on key takeaways and trends from recent pharma conferences.